Canada Life’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,085
| Closed | -$39K | – | 2792 |
|
|
2019
Q3 | $39K | Sell |
2,085
-1,845
| -47% | -$21.1K | ﹤0.01% | 1049 |
|
|
2019
Q2 | $46K | Buy |
+3,930
| New | +$47.6K | ﹤0.01% | 2465 |
|
|
2019
Q1 | – | Sell |
-5,234
| Closed | -$52K | – | 2741 |
|
|
2018
Q4 | $52K | Hold |
5,234
| – | – | ﹤0.01% | 2364 |
|
|
2018
Q3 | $87K | Hold |
5,234
| – | – | ﹤0.01% | 2240 |
|
|
2018
Q2 | $83K | Hold |
5,234
| – | – | ﹤0.01% | 2255 |
|
|
2018
Q1 | $67K | Hold |
5,234
| – | – | ﹤0.01% | 2292 |
|
|
2017
Q4 | $60K | Hold |
5,234
| – | – | ﹤0.01% | 2317 |
|
|
2017
Q3 | $60K | Hold |
5,234
| – | – | ﹤0.01% | 2298 |
|
|
2017
Q2 | $60K | Hold |
5,234
| – | – | ﹤0.01% | 2271 |
|
|
2017
Q1 | $108K | Hold |
5,234
| – | – | ﹤0.01% | 2098 |
|
|
2016
Q4 | $109K | Hold |
5,234
| – | – | ﹤0.01% | 2097 |
|
|
2016
Q3 | $171K | Hold |
5,234
| – | – | ﹤0.01% | 1947 |
|
|
2016
Q2 | $130K | Buy |
5,234
+2,534
| +94% | +$68.6K | ﹤0.01% | 2015 |
|
|
2016
Q1 | $66K | Hold |
2,700
| – | – | ﹤0.01% | 2017 |
|
|
2015
Q4 | $89K | Hold |
2,700
| – | – | ﹤0.01% | 1851 |
|
|
2015
Q3 | $89K | Hold |
2,700
| – | – | ﹤0.01% | 1787 |
|
|
2015
Q2 | $142K | Buy |
+2,700
| New | +$98.2K | ﹤0.01% | 1600 |
|
Canada Life's ALDR Position: Q4 2019 in Review
Canada Life sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,085 shares — an estimated $39K sold.
Canada Life first reported a position in ALDR in Q2 2015 and held it in 17 quarters. The position peaked at $171K in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Canada Life reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Canada Life sold 2,085 Alder Biopharmaceuticals shares in Q4 2019, an estimated $39K.
- Canada Life first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 17 quarters.
- Canada Life's Alder Biopharmaceuticals position peaked at $171K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Canada Life's 13F filing for Q4 2019, filed 11 Feb 2020.